Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.370
-0.090 (-3.66%)
At close: Dec 5, 2025, 4:00 PM EST
2.390
+0.020 (0.83%)
After-hours: Dec 5, 2025, 7:55 PM EST
Microbot Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Microbot Medical stock have an average target of 8.75, with a low estimate of 5.50 and a high estimate of 12. The average target predicts an increase of 269.20% from the current stock price of 2.37.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Microbot Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth Capital | Roth Capital | Strong Buy Initiates $5.5 | Strong Buy | Initiates | $5.5 | +132.07% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +406.33% | Nov 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +406.33% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +406.33% | Sep 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +279.75% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
306.00K
Revenue Next Year
6.94M
from 306.00K
Increased by 2,166.67%
EPS This Year
-0.32
from -0.73
EPS Next Year
-0.36
from -0.32
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 315,000 | 7.1M |
| Avg | 306,000 | 6.9M |
| Low | 294,000 | 6.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | - | 2,233.3% |
| Avg | - | 2,166.7% |
| Low | - | 2,077.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.33 | -0.37 |
| Avg | -0.32 | -0.36 |
| Low | -0.30 | -0.34 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.